Julia Bonavitacola

Racial disparities in food insecurity persisted despite income level in US households between 2000 and 2023.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

In a cohort of US veterans, there were reduced risks of adverse clinical outcomes in people with SUDs and of developing an SUD in those taking GLP-1s.

The Support, Educate, Empower intervention was able to reduce glaucoma-related distress compared with standard education.

The Conference on Retroviruses and Opportunistic Infections 2026 included breakthrough research and looked toward the future of HIV.

Patients with myasthenia gravis had a more consistent clinical response and fewer deteriorations when using add-on therapy early.

Measles outbreaks are emerging across the country, continuing the increasing trend in cases that began in 2025.

Presentations focused on the efficacy of long-acting cabotegravir, doravirine/islatravir, and bictegravir/lenacapavir when used as antiretroviral therapy.

Abstracts presented during the Conference on Retroviruses and Opportunistic Infections 2026 offered a glimpse into which therapies patients prefer to use to treat HIV.

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

A session at CROI 2026 opened with questions on how glucagon-like peptide-1 receptor agonists could be used in HIV.

Patients with ocular myasthenia gravis (MG) should be regularly assessed to reduce the chances of progression to generalized MG.

New research shows that adherence to antiretroviral therapy and pre-exposure prophylaxis depends on a steady budget through PEPFAR and SNAP.

Posters presented during the Conference on Retroviruses and Opportunistic Infections 2026 highlight the safe use of tirzepatide in patients with HIV.

The first full day of CROI 2026 featured a lecture that outlined the next steps in treating and preventing HIV.

Julie Rosenthal, MD, MS, discusses signs and symptoms of age-related macular degeneration as well as methods of treatment.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The conference, held in Denver, Colorado, promises presentations on breaking research and the future of prevention.

The changes in the CDC vaccine recommendations have affected public opinion and state-level decisions regarding mandates for vaccine uptake.

A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US.

Patients with myasthenia gravis (MG) had greater morbidity and extended hospitalization when they underwent cardiac surgery.

The serial monitoring of muscle-specific kinase (MuSK) antibodies could help in assessing the severity of the disease.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A stronger effect on neovascular age-related macular degeneration (nAMD) was found with faricimab vs aflibercept.

The Consolidated Appropriations Act of 2026 gives CMS more leverage to intercept when pharmacy benefit managers are driving up prices in Medicare Part D, explains Jesse Dresser, Esq.

The test was more likely to have a positive response in patients with a decrement after nerve stimulation.

The Consolidated Appropriations Act of 2026 acts as a first step in addressing prescription drug pricing challenges related to the role of pharmacy benefit managers (PBMs).

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

More than half of the young patients with myasthenia gravis (MG) responded well to the use of corticosteroids.

The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers (PBMs) operate in the US.